Skin Therapy Letter HOME
Written for dermatologists by dermatologists. Indexed by the US National Library of Medicine.
Skin Information
NETWORK
Skin Therapy Letter About STL Subscribe Today SkinCareGuide Network Site Map
CUSTOM DERMATOLOGY SEARCH:
Loading

Skin Therapy Letter: Volume 19 - 2014

  Number 5 • September-October 2014   |  Download PDF

Updates on the Management of Autoimmune Blistering Diseases
Joanna N. Hooten, MD1; Russell P. Hall 3rd, MD1,2; Adela R. Cardones, MD1,2
1Department of Dermatology, Duke University School of Medicine, Durham, NC, USA
2Division of Dermatology, Department of Medicine, Duke University Medical Center, Durham VA Medical Center, Durham, NC, USA

Pregnancy-Specific Skin Disorders
Skyler White, BS; Rebecca Philips, MD; Megan Moody Neill, MD; Erica Kelly, MD
Department of Dermatology, University of Texas Medical Branch, Galveston, TX, USA

Update on Drugs and Drug News: September-October 2014

Top

  Number 4 • July-August 2014   |  Download PDF

Sirolimus: A Therapeutic Advance for Dermatologic Disease
Tess Peters, MSc, MD; Danya Traboulsi, BSc; Lee Anne Tibbles MD, FRCPC; P. Régine Mydlarski MD, FRCPC
Faculty of Medicine, University of Calgary, Calgary, AB, Canada

Review of Evidence for Dietary Influences on Atopic Dermatitis
Sarah Mohajeri, MD, MPH and Sabrina A. Newman, MD
Dermatology and Internal Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA

Update on Drugs and Drug News: July-August 2014

Top

  Number 3 • May-June 2014   |  Download PDF

Rosacea: An Update on Medical Therapies
Brian Po-Yen Chang, BSc1; Anil Kurian, MD2; Benjamin Barankin, MD, FRCPC3
1Faculty of Medicine, University of Alberta, Edmonton, AB, Canada
2Division of Dermatology & Cutaneous Sciences, Department of Medicine, University of Alberta, Edmonton, AB, Canada
3Toronto Dermatology Centre, Toronto, ON, Canada

Recent Approval of Xerese in Canada: 5% Acyclovir and 1% Hydrocortisone Topical Cream in the Treatment of Herpes Labialis
Harrison P. Nguyen, BA1,2; Kelly R. Stiegel, BS1;
Christopher Downing, MD3; Stephen K. Tyring, MD, PhD, MBA2,3

1Department of Dermatology, Baylor College of Medicine, Houston, TX, USA
2Department of Dermatology, University of Texas Medical School at Houston, Houston, TX, USA
3Center for Clinical Studies, Houston, TX, USA

Update on Drugs and Drug News: May-June 2014

Top

  Number 2 • March-April 2014   |  Download PDF

Metastatic Melanoma: Optimizing Outcomes by Managing Dermatologic Toxicities Associated with Novel Therapies
Joel Claveau, MD, FRCPC, DABD;1 Vincent Ho, MD, FRCPC, FRCP (Lon);2 Teresa Petrella, MD, FRCPC3
1Centre Hospitalier Universitaire de Québec, Hôtel-Dieu de Québec, Melanoma and Skin Cancer Clinic, Quebec City, QC, Canada
2Department of Dermatologic Oncology, British Columbia Cancer Agency, and Department of Dermatology and Science, University of British Columbia, Vancouver, BC, Canada
3Division of Medical Oncology/Hematology, Odette Cancer Centre, Toronto, ON, Canada

An Update on the Clinical Management of Cutaneous Molluscum Contagiosum
Harrison P. Nguyen, BA1,2 and Stephen K. Tyring, MD, PhD, MBA2,3
1Baylor College of Medicine, Houston, TX, USA
2Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX, USA
3Center for Clinical Studies, Houston, TX, USA

Skin Treatments Introduced in 2013

Update on Drugs and Drug News: March-April 2014

Top

  Number 1 • January-February 2014   |  Download PDF

Efinaconazole: A New Topical Treatment for Onychomycosis
Aditya K. Gupta, MD, PhD, MBA, FAAD, FRCPC1,2 and Fiona C. Simpson, HBSc2
1Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada
2Mediprobe Research Inc., London, ON, Canada

Conflict of interest: Dr. Gupta has served as a clinical trials investigator for Valeant Pharmaceuticals Inc.

Steroid-Sparing Properties of Emollients in Dermatology
Sara Harcharik and Jason Emer, MD
The Mount Sinai School of Medicine, Department of Dermatology, New York, NY, US A
Conflict of interest: No conflicts of interest

Update on Drugs and Drug News: January-February 2014

Top